In this roundtable discussion with Dr. John Gribben, University of London, and Dr. Constantine Tam, Peter MacCallum Cancer Centre, Patient Power Founder, Andrew Schorr, asks the panelists to discuss the current frontline treatment advances for CLL. Listen as new research is discussed, including survival advantages and durable control, as well as cumulative toxicity and cost.
Where Are We Headed With Frontline CLL... - CLL America Support
Where Are We Headed With Frontline CLL Treatment Approaches?
Written by
mcints
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
New here. After 10 years of CLL, Ibrutinib treatment needed for decreasing hemoglobin and platelets.
I have avoided any treatment so far but extreme fatigue fluctuations have drastically restricted...
Choice of doctors
Ok so I've got a real dilemma. I'm on W&W. I have two top CLL specialists in two sister hospitals....
CLL diagnosis and diet
was Diagnosed with CLL a day after my 60th birthday party. I hadn't been feeling well for months. I...
Good News from the Doctor Venetoclax is working!
I started my Venetoclax journey September 7th. A few bumps on the way up from 20mgs. to 400 mgs....
I’m unclear what to think of my diagnosis
I’m new here and not clear about the diagnosis given on my Flow Cytometry, which classified me with...
I'm new to the site
Treatmant for cll
Anxiety
Hubby about to begin Obinutuzumab infusions....feeling anxious
Venetoclax and spleen enlarging
